Curetis is not your typical biotech start-up. We are rather a newcomer with many years of multi-disciplinary expertise. Over the past years we have created a healthy growth story. We have convinced our customers and partners, with our pioneering spirit, coupled with the simple aspiration „We care for Diagnostics“, our engineering prowess, and molecular biology and microbiological expertise.
We are not a typical R&D driven company. We rather put our focus on commercial product development. We listen carefully and flexibly react to market and customer demands and needs. We strive to address these by way of pragmatic and intelligent solutions such as Unyvero.
Curetis Receives USPTO Notice of Allowance for Key Patent Covering Unyvero Technology
Curetis subsidiary Ares Genetics wins incubator stay in Silicon Valley
Deutsche Biotechnologietage 2018 - Berlin, Germany - April 18 to 19, 2018
28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Madrid, Spain - 21 to 24 April, 2018